Biotage India Profile
Key Indicators
- Authorised Capital ₹ 2.05 Cr
as on 08-12-2024
- Paid Up Capital ₹ 2.05 Cr
as on 08-12-2024
- Company Age 7 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 325.90%
(FY 2020)
- Profit 82.52%
(FY 2020)
- Ebitda 96.35%
(FY 2020)
- Net Worth -13.09%
(FY 2020)
- Total Assets 91.98%
(FY 2020)
About Biotage India
The Company is engaged in the Machinery And Equipment Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.05 Cr and a paid-up capital of Rs 2.05 Cr, as per Ministry of Corporate Affairs (MCA) records.
Nimisha Pandey, Tomas Blomquist, Lars Backman, and One other member serve as directors at the Company.
- CIN/LLPIN
U74999DL2017FTC364509
- Company No.
300714
- Company Classification
Private Limited Foreign Company Incorporated In India
- Incorporation Date
11 Oct 2017
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Biotage India Private Limited offer?
Biotage India Private Limited offers a wide range of products and services, including Laboratory & Lab Equipment, Laboratory Reactors.
Who are the key members and board of directors at Biotage India?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nimisha Pandey  | Director | 11-Oct-2018 | Current |
Tomas Blomquist  | Director | 11-Feb-2020 | Current |
| Lars Backman | Director | 11-Feb-2020 | Current |
| Scott Carr | Additional Director | 27-Sep-2024 | Current |
Financial Performance of Biotage India.
Biotage India Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 325.9% increase. The company also saw a substantial improvement in profitability, with a 82.52% increase in profit. The company's net worth observed a substantial decline by a decrease of 13.09%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Biotage India?
In 2020, Biotage India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Biotage India?
Biotage India has a workforce of 11 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Biotage India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biotage India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
